{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"}],"units":"Participants"}],"description":"Overall survival at last follow-up will be determined.","groups":[{"description":"Patients receive soy isoflavones PO for approximately 14 days before undergoing surgery.","id":"OG000","title":"Treatment (Soy Isoflavones)"}],"paramType":"NUMBER","populationDescription":"55 patients were enrolled. 3 patients did not undergo treatment. 13 patients had insufficient tissue and were therefore not evaluable. Only the 39 evaluable patients were included in the analysis.","reportingStatus":"POSTED","timeFrame":"Up to 24 months","title":"The Number of Participants Alive at Follow-up","type":"SECONDARY","unitOfMeasure":"participants"}